Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Role for Nrf2 and exercise in mitigating pulmonary hypertension-induced vascular dysfunction

Award Number: F31HL170643
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 09/01/2023
PERIOD OF PERFORMANCE END DATE: 05/31/2025

Group Awards By:

View Award Description

Role for Nrf2 and exercise in mitigating pulmonary hypertension-induced vascular dysfunction - PROJECT SUMMARY/ABSTRACT Pulmonary hypertension (PH) is a disease characterized by pulmonary vascular remodeling and poor gas exchange, and eventually leads to right ventricular failure and death. Elevated heart and respiratory muscle workloads contribute to diaphragm and cardiac impairments in PH; however, the physiological and molecular bases are not fully understood. Vascular function is compromised in PH, resulting in an inability to match oxygen delivery to demand, which is of increasing importance in the overworked diaphragm and heart. However, the mechanisms underlying PH-induced vascular dysfunction and, arguably more important, targets for mitigating such dysfunction remain unknown. Upregulation of reactive oxygen species and inflammatory cytokines are thought to promote PH pathogenesis, which suggests that modulation of intracellular redox pathways may serve as one potential mechanism responsible for the impaired vasomotor control with PH and provides a potential therapeutic target to improve the compromised vascular function in PH. Preliminary data supports that PH impairs endothelial-dependent and -independent vasorelaxation in diaphragm arterioles, and therefore diaphragmatic blood flow. Importantly, endothelial-dependent and - independent vasoreactivity may be improved by activation of the transcription factor, nuclear factor erythroid- 2–related factor 2 (Nrf2). However, the role of Nrf2 in improving coronary and diaphragm vascular function in PH has never been determined. Therefore, our global hypothesis is that exercise training and pharmacological Nrf2 activation will improve or restore coronary and diaphragm vascular function in PH. Furthermore, we will assess the reliance upon Nrf2 for these adaptations in order to determine the potential molecular basis for our findings. This project will be completed at Kansas State University (KSU) under the guidance of Drs. David C. Poole and Bradley J. Behnke. The training plan has been formulated to facilitate the development of technical proficiencies and critical thinking skills needed to execute the proposed experiments and incorporates the elements essential for the applicant to transition into an independent scientific career. The Poole and Behnke Laboratories, and the Departments of Kinesiology and Anatomy and Physiology at KSU represent a rich scientific environment that will provide outstanding graduate training and research opportunities to gain new insights into mechanisms of diaphragm blood flow regulation and vasomotor control in healthy and diseased animal models.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$967 )
2026	2024	KANSAS STATE UNIVERSITY	1601 VATTIER STREET	MANHATTAN	KS	66506	RILEY	USA	Lung Diseases Research	000	2	4/22/2026	NON-COMPETING CONTINUATION	-$967
														Subtotal = -$967

Issue Date FY: 2025 ( Subtotal = -$7,281 )
2025	2024	KANSAS STATE UNIVERSITY	1601 VATTIER STREET	MANHATTAN	KS	66506	RILEY	USA	Lung Diseases Research	000	2	8/29/2025	NON-COMPETING CONTINUATION	-$7,281
														Subtotal = -$7,281

Issue Date FY: 2024 ( Subtotal = $36,922 )
2024	2024	KANSAS STATE UNIVERSITY	1601 VATTIER STREET	MANHATTAN	KS	66506	RILEY	USA	Lung Diseases Research	000	2	8/22/2024	NON-COMPETING CONTINUATION	$36,922
														Subtotal = $36,922

Issue Date FY: 2023 ( Subtotal = $35,642 )
2023	2023	KANSAS STATE UNIVERSITY	1601 VATTIER STREET	MANHATTAN	KS	66506	RILEY	USA	Lung Diseases Research	001	1	8/28/2023	NEW	$0
2023	2023	KANSAS STATE UNIVERSITY	1601 VATTIER STREET	MANHATTAN	KS	66506	RILEY	USA	Lung Diseases Research	000	1	8/28/2023	NEW	$35,642
														Subtotal = $35,642

Grand Total All Awards = $64,316

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Role for Nrf2 and exercise in mitigating pulmonary hypertension-induced vascular dysfunction

Award Number: F31HL170643

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 09/01/2023

PERIOD OF PERFORMANCE END DATE: 05/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer